Newsroom
-
January 23 , 2024
Sanofi to Acquire Inhibrx, Inc., Adding Potential Best-in-class Rare Disease Asset for Alpha-1 Antitrypsin Deficiency to Pipeline
Read more
-
January 22 , 2024
Gilead Provides Update On Phase 3 EVOKE-01 Study
Read more
-
January 16 , 2024
Orion to Buy Control of Biotech Startup LegoChem for $415 mn
Read more
-
January 10 , 2024
GSK Enters Agreement to Acquire Aiolos Bio
Read more
-
January 9 , 2024
Ambrx Announces Sale to Johnson & Johnson
Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Read More
